
Giulia Marvaso/X
May 5, 2025, 15:50
Giulia Marvaso Highlights Evolving Evidence on SBRT and MDT Strategies at ESTRO25
Giulia Marvaso, Assistant Professor in the Department of Oncology and Hemato-Oncology at the University of Milan and Radiation Oncologist at IEO Milan, shared a post on X:
“Live from ESTRO25:
From STOMP , EXTEND to RADIOSA and X-MET—the evidence is growing:
SBRT alone is good.
SBRT + ADT is better.
Personalized MDT strategies are here to stay.Stronger together”
More posts featuring ESTRO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 5, 2025, 15:10
May 5, 2025, 15:06
May 5, 2025, 14:43